| Brooks Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.07 | 0.10 | 0.10 | 0.11 | 0.22 |
| Long Term Debt-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.08 |
| Current Ratio | 1.41 | 1.05 | 0.94 | 1.02 | 0.88 |
| Fixed Assets | 3.41 | 3.45 | 2.53 | 3.78 | 1.02 |
| Inventory | 8.78 | 7.60 | 3.98 | 5.31 | 5.91 |
| Debtors | 4.55 | 5.47 | 4.00 | 6.25 | 6.14 |
| Interest Cover Ratio | 4.14 | 2.86 | -9.62 | 1.61 | -1.60 |
| PBIDTM (%) | 7.10 | 5.25 | -10.26 | 3.33 | 2.47 |
| PBITM (%) | 5.16 | 3.02 | -13.36 | 1.39 | -6.70 |
| PBDTM (%) | 5.85 | 4.19 | -11.65 | 2.46 | -1.73 |
| CPM (%) | 5.63 | 4.15 | -11.63 | 2.47 | -11.00 |
| APATM (%) | 3.69 | 1.92 | -14.73 | 0.53 | -20.18 |
| ROCE (%) | 3.19 | 2.72 | 0.00 | 1.23 | 0.00 |
| RONW (%) | 2.43 | 1.90 | 0.00 | 0.52 | 0.00 |